# Composition for Treating Spermatogenesis and Semen Disorders / FPT-20

> **NCT05399212** · PHASE4 · COMPLETED · sponsor: **Trieu, Nguyen Thi, M.D.** · enrollment: 60 (actual)

## Conditions studied

- Spermatogenesis and Semen Disorders

## Interventions

- **DRUG:** FPT-20

## Key facts

- **NCT ID:** NCT05399212
- **Lead sponsor:** Trieu, Nguyen Thi, M.D.
- **Sponsor class:** INDIV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-29
- **Primary completion:** 2022-05-20
- **Final completion:** 2022-05-20
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-05-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05399212

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05399212, "Composition for Treating Spermatogenesis and Semen Disorders / FPT-20". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT05399212. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*